Search Tag: Haystack Oncology
2022 01 Dec
Haystack Oncology, an oncology company that applies the next generation of circulating tumor DNA (ctDNA) detection technology to optimize minimal residual disease (MRD) testing and better inform decisions around therapy announced the appointment of Joel Kaufman as Chief Financial Officer. Mr. Kaufman joins Haystack with over a decade of experience...Read more